IL-23 ANTIBODY COMPOSITIONS AND METHODS OF USE
Patent Information
- Application Number
- ARP20250100308
- Authority / Receiving Office
- AR · AR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-09-24
- Filing Date
- 2025-02-05
- Publication Date
- 2026-07-08
Claims
This document provides IL-23 binding proteins (e.g., antibodies) and methods of use.
1. An IL-23 binding protein comprising a heavy chain variable domain (VH) comprising complementarity-determining regions: CDR-H1 comprising the amino acid sequence of SEQ ID No. 131; CDR-H2 comprising the amino acid sequence of SEQ ID No. 132; and CDR-H3 comprising the amino acid sequence of SEQ ID No.
133.
45. An isolated nucleic acid encoding an IL-23 binding protein of any of claims 1-44.
46. An expression vector comprising the isolated nucleic acid of claim 45.
47. A host cell comprising the isolated nucleic acid molecule of claim 45 or the expression vector of claim 46.
48. A composition comprising an IL-23 binding protein of any of claims 1-44 and a pharmaceutically acceptable carrier.